Background

The Medicines Verification Capability was introduced as part of GPIT Futures to support the EU Directive on Falsified Medicines Directive (FMD). Since then, the UK has left the European Union and the FMD was not part of the withdrawal agreement. 

There is work to introduce an equivalent UK service, however, there are currently no timescales available for an implementation date. 

Therefore, to provide clarity to Suppliers this Roadmap item will retire the Medicines Verification Capability and the Interoperability Standard relating to the National Medicines Verification Service.

Outline Plan

As there is expected to be a replacement UK service with similarities to the EU service, Suppliers who previously mapped to the Medicines Verification Capability may want to retain any functionality/code/documentation.

It is expected when there is clarity on the replacement service that a new Capability and Interoperability Standard will be added.

Summary of Change

Summary of model updates:

• Retire Medicines Verification Capability
• Retire National Medicines Verification System Standard
• Remove National Medicines Verification System Standard from main Interoperability Standard

Interoperability Standard

Updates:

Medicines Verification

Full Specification

Interoperability Standard v14.0.1

Assurance Approach

N/A